---
figid: PMC5568011__nihms890979f7
figtitle: MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating
  insulin signaling and impairing lipogenesis
organisms:
- Escherichia coli
- Escherichia coli SCD1
- Homo sapiens
- Mus musculus
- Bos taurus
- vectors
- Adeno-associated virus
- Acanthobothrium sp. 1
pmcid: PMC5568011
filename: nihms890979f7.jpg
figlink: /pmc/articles/PMC5568011/figure/F7/
number: F7
caption: HFD treatment impairs miR-206 biogenesis. Ptpn1 encodes a non-receptor phospho-tyrosine
  protein phosphatase (Ptp1b), which can dephosphorylate Insr, Irs and PP2A (phosphatase
  2A). By targeting Ptpn1, miR-206 prevents dephosphorylation of Insr and Irs1, which
  subsequently improves insulin sensitivity and prevents gluconeogenesis. PP2A is
  able to activate Srebp1c transcription by dephosphorylating Sp1, a transcription
  factor of Srebp1c. Thus, miR-206 is able to inhibit lipogenesis via the Ptpn1-PP2A-Sp1-Srebp1c
  pathway. Thus, miR-206 can simultaneously improve insulin sensitivity through Ptpn1-Insr/Irs1
  and inhibit lipogenesis via Ptpn1-Pp2a-Sp1-Srebp1c axis.
papertitle: MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating
  insulin signaling and impairing lipogenesis.
reftext: Heng Wu, et al. J Hepatol. 2017 Apr;66(4):816-824.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9021594
figid_alias: PMC5568011__F7
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Bos taurus
redirect_from: /figures/PMC5568011__F7
ndex: 41bfc167-df13-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5568011__nihms890979f7.html
  '@type': Dataset
  description: HFD treatment impairs miR-206 biogenesis. Ptpn1 encodes a non-receptor
    phospho-tyrosine protein phosphatase (Ptp1b), which can dephosphorylate Insr,
    Irs and PP2A (phosphatase 2A). By targeting Ptpn1, miR-206 prevents dephosphorylation
    of Insr and Irs1, which subsequently improves insulin sensitivity and prevents
    gluconeogenesis. PP2A is able to activate Srebp1c transcription by dephosphorylating
    Sp1, a transcription factor of Srebp1c. Thus, miR-206 is able to inhibit lipogenesis
    via the Ptpn1-PP2A-Sp1-Srebp1c pathway. Thus, miR-206 can simultaneously improve
    insulin sensitivity through Ptpn1-Insr/Irs1 and inhibit lipogenesis via Ptpn1-Pp2a-Sp1-Srebp1c
    axis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mir206
  - Insr
  - Ptpn1
  - Ppp2ca
  - Ppp2r1a
  - Sp1
  - Irs1
  - Pik3r1
  - Akt1
  - Pck1
  - G6pc1
  - Tsc2
  - MIR206
  - INSR
  - IGF1R
  - INSRR
  - PTPN1
  - PTPA
  - SP1
  - PSG1
  - DAND5
  - IRS1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - PCK2
  - G6PC1
---
